India-Sweden Healthcare Innovation Centre launches ‘Innovation Challenge’
It is an opportunity for start-ups to collaborate with partners on the Innovation Centre platform to help solve some of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AstraZeneca Pharma India
Astrazeneca’s Dapagliflozin gets DCGI nod for treatment of heart failure
Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart…
AstraZeneca gets marketing permission for leukaemia drug in India
The receipt of this permission paves way for the launch of the capsules in India AstraZeneca Pharma has received approval from…
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'
AstraZeneca Pharma India to close Bengaluru API unit
The drug firm is shutting down the unit because of the low demand for the product in the export markets
AstraZeneca Pharma launches Forxiga in India
Forxiga is indicated to be used as an adjunct to diet and exercise in combination with other glucose-lowering medicinal products,…
DRL in agreement with AstraZeneca Pharma India for Riax and Riax M
DRL will be distributing Riax and Riax M in India Dr Reddy’s Laboratories (DRL) and AstraZeneca Pharma India have entered into a…